Physician profile
Bart A Chess
NPI 1023037413
$11,100.63
in general payments reported to CMS, 2019-2025
14 companies · $5,216 in 2025
The $5,216 reported for 2025 was more than what 85% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $929 · 2020: $461 · 2021: $470 · 2022: $1,767 · 2023: $1,345 · 2024: $913 · 2025: $5,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,570 · Travel and Lodging: $2,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,570.22 |
| Travel and Lodging | $2,903.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,560.19 | 2021-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Endoprosthesis |
| Medtronic, INC. | $2,737.22 | 2021-2025 | Endurant Iis, Na, Heli-Fx Endoanchor System |
| Terumo Medical Corporation | $1,169.66 | 2019-2025 | Azur Cx Detachable |
| Silk Road Medical, INC. | $1,103.88 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $892.20 | 2023-2025 | General - Vascular Access, Ranger, Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $627.02 | 2019-2025 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| Cook Medical LLC | $445.45 | 2025 | Zilver Ptx, Lunderquist, Cook |
| Centerline Biomedical INC. | $130.82 | 2020 | |
| Bolton Medical INC | $111.84 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Shape Memory Medical INC. | $105.65 | 2025 | Impede Embolization Plug |
| Medtronic Vascular, INC. | $83.12 | 2020 | |
| Ethicon US, LLC | $78.30 | 2021-2024 | Surgicel Nu-Knit |
| Abiomed | $37.41 | 2024 | Impella |
| Smith+Nephew, INC. | $17.87 | 2024 | Renasys Go V2 Home, Pico |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$704,647.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bart Chess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.